Papers

2

Total Citations

18

H-Index

2

About

Dr. Vikas Prasad is a leading figure in nuclear medicine and theranostics, with a particular focus on advancing cancer care in India and globally. His work bridges the critical gap between emerging radiotheranostic technologies and their clinical implementation, especially in resource-constrained settings. Dr. Prasad’s major contributions include pioneering research on the use of dynamic 18F-FET PET/CT to differentiate recurrent brain tumors from radiation necrosis following single-session robotic radiosurgery—a diagnostic challenge with profound treatment implications. This work, alongside his comprehensive analysis of India’s growing nuclear medicine infrastructure, has positioned him as a key voice in expanding access to precision oncology. His 2023 paper on India’s radiotheranostics landscape, with 14 citations, highlights both the opportunities and systemic challenges in deploying targeted radionuclide therapies for cancer. Dr. Prasad’s research not only advances clinical diagnostics but also advocates for strategic international collaboration, making him a vital contributor to the global dialogue on nuclear medicine’s role in equitable cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
18
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate
14 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Washington University in St. Louis, Humboldt-Universität zu Berlin

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago